Shin Jeon1,2,3,9, Jaein Park1,2,9, Ji Hwan Moon1,2,4,9, Dongjun Shin1,2, Liwen Li1,2, Holly O’Shea1,2, Seon-Ung Hwang1,2, Hyo-Jong Lee5, lise Brimble6,7, Jae W. Lee1,2, Stewart D. Clark8 & Soo-Kyung Lee1,2
1Department of Biological Sciences, College of Arts and Sciences, University at Buffalo, The State University of New York (SUNY), Buffalo, New York, USA.
2FOXG1 Research Center, University at Buffalo, The State University of New York (SUNY), Buffalo, NY, USA.
3Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
4Samsung Genome Institute, Samsung Medical Center, Seoul, South Korea.
5School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.
6FOXG1 Research Foundation, Port Washington, New York, USA.
7Citizen Health, San Francisco, California, USA.
8Department of Pharmacology and Toxicology, University at Buffalo, The State University of New York (SUNY), Buffalo, NY, USA.
9These authors contributed equally: Shin Jeon, Jaein Park, Ji Hwan Moon.
Corresponding authors
Correspondence to Shin Jeon or Soo-Kyung Lee.